Navigation Links
MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
Date:11/17/2010

GAITHERSBURG, Md., Nov. 17, 2010 /PRNewswire/ -- MedImmune announced the winners of its 5th Annual Research Abstract Competition highlighting the work of the next generation of scientific leaders performing research in areas of respiratory, inflammation and autoimmune (RIA) disease. Graduate students and postdoctoral fellows from around the world were invited to submit abstracts on RIA research as part of a competition sponsored by MedImmune, AstraZeneca's global biologics unit.

First prize of $2,000 was awarded to Jennifer Martinez, Ph.D., Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, for her research topic "The role of LC3- associated phagocytosis in the clearance of dead cells."

Martinez noted: "I am appreciative for the recognition and the opportunity to present my data.  It was also a great chance to learn about research in the field my colleagues are doing around the world."  

Second and third prizes of $1,000 and $500 were awarded respectively to Jeremy Di Domizio, Ph.D., Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, and Donald Simons, Ph.D., of The Wistar Institute, Philadelphia.

"We are impressed by the quality of research that is being conducted by young scientists," said Bahija Jallal, executive vice president of research and development at MedImmune. "This competition, which is one of the many activities MedImmune leads to engage emerging scientists in advancing health and science education, uncovered some extraordinary ideas that could help researchers further understand approaches in the RIA therapeutic area."

The competition was open to graduate students and postdoctoral fellows worldwide, with ten finalists selected to present their research to a panel of MedImmune experts at the company's headquarters in Gaithersburg.  Evaluation of abstracts were based on the following criteria: scientific rationale, descripti
'/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MedImmune Focused on Revolutionizing Cancer Care
2. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
3. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
4. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
5. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
6. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
7. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
8. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
11. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... Court for the District of New Jersey ... company,s case against Sandoz, Inc. regarding United Therapeutics, Remodulin ... ruled that U.S. Patent No. 6,765,117 is both ... from marketing its generic product until the expiration of ...
(Date:8/29/2014)... 29, 2014 According to ... & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), ... QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global ... Oligonucleotide Synthesis Market is expected to reach $1,712.1 ... growing at a CAGR of 9.8% from 2014 ...
(Date:8/29/2014)... YORK, Pa. , Aug. 29, 2014  Unilife ...  ASX: UNS) announced today that it intends to release ... and year ended June 30, 2014 after market trading ... Management has scheduled a conference call for 4:30 p.m. ... 10, 2014 at 6:30 a.m. AEST), to review the Company,s ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... CINCINNATI, July 7 Procter & Gamble Pharmaceuticals (P&GP) ... tablets, which are indicated for the treatment of moderately ... disease. UC involves inflammation of the lining of the ... followed by periods of remission. Moderately active UC is ...
... Tenn., July 6 /PRNewswire/ -- A Pebble Beach ... cure for multiple sclerosis. The researchers took home the top ... and the non-profit Band Against MS (BAMS) organization. The money ... at the University of Texas Health Science Center at ...
Cached Medicine Technology:Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 2Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 3Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 4Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets 5Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research 2
(Date:9/1/2014)... Wellesley, Mass., (PRWEB) September 01, 2014 ... report, BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS ... reached $21.8 million in 2013 and is expected to ... further grow to $471.5 million by 2019, which is ... 2014 through 2019. The receptor-mediated transport (RMT) segment is ...
(Date:9/1/2014)... September 01, 2014 Registration is now open ... 5K and 1-Mile Race to be held on Sunday, September ... Court Yard at Harmon Meadow in Secaucus, New Jersey. All ... a national nonprofit dedicated to restoring a sense of self, ... members and our military families. , General registration is $30 ...
(Date:9/1/2014)... The Outlier Series announced the next short ... from one of the exceptional women featured in the ... Changers . The title of the upcoming mini e-Book ... McClendon . McClendon is currently a full-time physician’s assistant, ... of WeTV show, Raising Sextuplets. , Jenny was chosen ...
(Date:9/1/2014)... 2014 Beginning Tuesday, September 2nd, Las ... professionals and 10,000 consumers for the annual gathering known ... of the nation’s top medical professionals who specializes in ... The week-long event contains more than 120 hours of ... in the pain management field. , MarijuanaDoctors.com is pleased ...
(Date:8/31/2014)... 31, 2014 MYMOBILEUNI (MMU) strategy ... social media marketing tools access to digital, resources, ... will utilize all tools to reach and collaborate ... our multiple learning channels. , MMU, today announced ... an authoring tool that applies social networking concepts ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3
... have some beneficial effects in fighting cancer, new research ... potential to perform better with this ingredient//. ,Vaccines work ... tissues and destroy them. But often, the immune system ... the healthy ones. ,But researchers at University ...
... Court would pass judgment regarding an appeal by health officials, ... a 17-month-old boy die//. Lawyers who are currently handling the ... of life is so poor and that doctors should be ... the boy and the treating physicians have not been revealed ...
... researchers said that mammograms were able to detect non ... Some previous studies// show that 54% of the mammograms ... rate is about 1% only. But the present study ... ,Dr. Sophia Zackrisson, a radiologist from the Epidemiological Research ...
... Center have zoned in on new molecular indicators, called ... be an interesting pointer when evaluating anti-aging therapies. The ... latest issue of the Journal of Investigative Dermatology. ... and cosmetic industries in developing products that will minimize ...
... who use the Internet more frequently are found to ... and social lives. Studies also suggested// that there is ... ,The Rotterdam-based Institute for Research into Lifestyles and Addiction ... 15 and found that what it termed "compulsive internet ...
... recent mental health study conducted by Dr. Michelle Hindin ... their parents are at an increased risk// of developing ... the respondents reported witnessing parental domestic violence. ... 5 female adolescents wished that they had died in ...
Cached Medicine News:Health News:Life Or Death: Parents Await High Court Judgment 2Health News:Mammograms Detect Non Progressive Cancer 2Health News:Biomarkers Could Prove Significant In Understanding Aging Process 2
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
... A revolutionary urological imaging ... benefits that translate into improved ... x 1k imaging technology physicians ... to see more anatomical detail ...
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
Medicine Products: